Examination of effect of yokukansan in prevention of the delirium after the surgical operation.

Trial Profile

Examination of effect of yokukansan in prevention of the delirium after the surgical operation.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jan 2017

At a glance

  • Drugs TJ 54 (Primary)
  • Indications Delirium
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Jan 2017 Primary endpoint (Postoperative delirium incidence) has not been met.
    • 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium
    • 01 Jun 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top